Cytokrome P450- enzymer, effluxpumper og proteinbindende mekanismer er ikke indblandet i clearance af omalizumab; der er derfor lille potentiale for lægemiddel- lægemiddel- interaktioner.
Cytochrome P450 enzymes, efflux pumps and protein-binding mechanisms are not involved in the clearance of omalizumab; thus, there is little potential for drug-drug interactions.